Literature DB >> 10511836

Lifetime health and economic benefits of weight loss among obese persons.

G Oster1, D Thompson, J Edelsberg, A P Bird, G A Colditz.   

Abstract

OBJECTIVES: This study estimated the lifetime health and economic benefits of sustained modest weight loss among obese persons.
METHODS: We developed a dynamic model of the relationship between body mass index (BMI) and the risks and costs of 5 obesity-related diseases: hypertension, hypercholesterolemia, type 2 diabetes, coronary heart disease (CHD), and stroke. We then calculated the lifetime health and economic benefits of a sustained 10% reduction in body weight for men and women aged 35 to 64 years with mild, moderate, and severe obesity.
RESULTS: Depending on age, gender, and initial BMI, a sustained 10% weight loss would (1) reduce the expected number of years of life with hypertension, hypercholesterolemia, and type 2 diabetes by 1.2 to 2.9, 0.3 to 0.8, and 0.5 to 1.7, respectively; (2) reduce the expected lifetime incidence of CHD and stroke by 12 to 38 cases per 1000 and 1 to 13 cases per 1000, respectively; (3) increase life expectancy by 2 to 7 months; and (4) reduce expected lifetime medical care costs of these 5 diseases by $2200 to $5300.
CONCLUSIONS: Sustained modest weight loss among obese persons would yield substantial health and economic benefits.

Entities:  

Mesh:

Year:  1999        PMID: 10511836      PMCID: PMC1508787          DOI: 10.2105/ajph.89.10.1536

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  33 in total

1.  The cost of obesity: the US perspective.

Authors:  A M Wolf; G A Colditz
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

2.  The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension.

Authors:  S Wassertheil-Smoller; M D Blaufox; A S Oberman; H G Langford; B R Davis; J Wylie-Rosett
Journal:  Arch Intern Med       Date:  1992-01

Review 3.  Medical hazards of obesity.

Authors:  F X Pi-Sunyer
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

4.  Risk of symptomatic gallstones in women with severe obesity.

Authors:  M J Stampfer; K M Maclure; G A Colditz; J E Manson; W C Willett
Journal:  Am J Clin Nutr       Date:  1992-03       Impact factor: 7.045

5.  Variability of body weight and health outcomes in the Framingham population.

Authors:  L Lissner; P M Odell; R B D'Agostino; J Stokes; B E Kreger; A J Belanger; K D Brownell
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

6.  Weight gain as a risk factor for clinical diabetes mellitus in women.

Authors:  G A Colditz; W C Willett; A Rotnitzky; J E Manson
Journal:  Ann Intern Med       Date:  1995-04-01       Impact factor: 25.391

7.  Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients.

Authors:  G Oster; D M Huse; M J Lacey; A M Epstein
Journal:  Stroke       Date:  1994-06       Impact factor: 7.914

Review 8.  Long-term effects of change in body weight on all-cause mortality. A review.

Authors:  R Andres; D C Muller; J D Sorkin
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

9.  Weight loss and subsequent death in a cohort of U.S. adults.

Authors:  E R Pamuk; D F Williamson; M K Serdula; J Madans; T E Byers
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

10.  Serum cholesterol profiles during treatment of obese outpatients with a very low calorie diet. Effect of initial cholesterol levels.

Authors:  J Osterman; T Lin; H R Nankin; K A Brown; C A Hornung
Journal:  Int J Obes Relat Metab Disord       Date:  1992-01
View more
  33 in total

Review 1.  Socioeconomic issues affecting the treatment of obesity in the new millennium.

Authors:  L F Martin; A Robinson; B J Moore
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

Review 2.  Treatment of the metabolic syndrome: the impact of lifestyle modification.

Authors:  Allison M Pritchett; John P Foreyt; Douglas L Mann
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

3.  What can the National Weight Control Registry teach us?

Authors:  Elizabeth Daeninck; Marsha Miller
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

Review 4.  Cardiovascular effects of bariatric surgery.

Authors:  Andrew J Beamish; Torsten Olbers; Aaron S Kelly; Thomas H Inge
Journal:  Nat Rev Cardiol       Date:  2016-10-20       Impact factor: 32.419

5.  Weight loss maintenance strategies among rural breast cancer survivors: The rural women connecting for better health trial.

Authors:  Christie A Befort; Jennifer R Klemp; Debra K Sullivan; Theresa Shireman; Francisco J Diaz; Kathryn Schmitz; Michael G Perri; Carol Fabian
Journal:  Obesity (Silver Spring)       Date:  2016-09-01       Impact factor: 5.002

Review 6.  The effects of capsaicin and capsiate on energy balance: critical review and meta-analyses of studies in humans.

Authors:  Mary-Jon Ludy; George E Moore; Richard D Mattes
Journal:  Chem Senses       Date:  2011-10-29       Impact factor: 3.160

Review 7.  Cardiovascular, renal and overall health outcomes after bariatric surgery.

Authors:  Ji C Tham; Carel W le Roux; Neil G Docherty
Journal:  Curr Cardiol Rep       Date:  2015-05       Impact factor: 2.931

Review 8.  Social Media and Obesity in Adults: a Review of Recent Research and Future Directions.

Authors:  Molly E Waring; Danielle E Jake-Schoffman; Marta M Holovatska; Claudia Mejia; Jamasia C Williams; Sherry L Pagoto
Journal:  Curr Diab Rep       Date:  2018-04-18       Impact factor: 4.810

9.  Halting the obesity epidemic: a public health policy approach.

Authors:  M Nestle; M F Jacobson
Journal:  Public Health Rep       Date:  2000 Jan-Feb       Impact factor: 2.792

10.  The influence of sex and obesity phenotype on meal fatty acid metabolism before and after weight loss.

Authors:  Sylvia Santosa; Donald D Hensrud; Susanne B Votruba; Michael D Jensen
Journal:  Am J Clin Nutr       Date:  2008-10       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.